MD, PhD. Physician Scientist in Endocrinology and Metabolism. Research on type 2 diabetes, obesity and stress response pathways (Keap1/Nrf2, Fgf21, Notch).
As an endocrinologist doing research on obesity for about 18 years and working currently in an obesity outpatient clinic, I am happy to see @TheEconomist addressing it in the front page. Details regarding the side-effects of GLP-1 agonists warrant further clarification though.
Review article - Circulation Research
Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms
Ira J. Goldberg, Martin E. Young, P. Christian Schulze, Konstantinos Drosatos
https://t.co/51z3UBt4Iu
Had coffee with a mentor of mine. He helped me during the early parts of my journey. He invested in my career and in me.
Now, retired, we try and grab a coffee every few months so I can keep him updated on how things are moving along.
“Are you investing in people?”
Me: I am 🥹
Yep: he’s who taught me coffee kindness and to invest in others 💪 and it’s an honor to pay it forward.
Honored to be invited to give the obituary of my mentor and friend Tom Kensler who passed away last summer due to an unfortunate hiking accident. @benbedphar 11th and last Nrf2 meeting , Istanbul, Turkey
Happy Birthday Giannis Botsis ! All the best !! @EvanFourmizz please take a look at the birthday cake his wife prepared for my cousin and he has just turned 42 ! Big fans !
Thomas W. Kensler, PhD, a trailblazer in cancer prevention who was among the first to conduct Westernized human clinical trials in China, died July 11, 2025, at the age of 76. We offer heartfelt condolences to his family, friends, and colleagues.
https://t.co/KxWTq8Hwbz
Our current issue's special collection of Physician-Scientist Development articles includes an editorial by Editor in chief @Eickelberg_MD & is paired with a cover collage of children's drawings illustrating what a 'physician-scientist' means to them: https://t.co/07oGjMYnJ6
“Modulating adipose progenitor cell function could improve strategies for treating adipose tissue dysfunction and metabolic diseases in obesity” @NatureRevEndo https://t.co/AafJBDzvvI
Trainees, please start with the assumption that the antisera (and other reagents) you use may not be fully validated. Then do your best to scrutinize and validate. This effort is tedious and frustrating but may save you some heartache. https://t.co/WDjN7l2t6w
Dear colleagues, please consider submitting your work on obesity, diabetes and metabolic diseases in this special issue. Do not hesitate to contact me directly if you need more info, extension of deadlines, open access charges. #obesity#diabetes#oxidative#stress#Nrf2#Notch
A wonderful basic and translational science symposium on the role of nuclear receptors in circadian rhythms and their effect on metabolism and cancer by Dr Lazar, Dr Shafi et Dr Adlanmerini. See you all next year in Boston! @TheEndoSociety#ENDO2023